A Look at the Treatment of Inflammatory Diseases of the Pharynx from the Perspective of a Reasonable Drug Policy
The article presents the biological and pharmacological properties of lysozyme and pyridoxine. Their antibacterial, antifungal, antiviral, immunomodulatory and anti-inflammatory mechanisms of action are described. The expediency of widespread use of topical drugs that enhance the protective functions of the mucous membrane in inflammatory pathology of the oropharynx is emphasized. Such drugs include the drug ZOTT. Its use is associated with an increase in the oropharynx of innate protection against pathogenic bacteria, fungi and viruses, as well as an increase in the effectiveness of systemic antibiotic therapy in the presence of biofilms.